GlaxoSmithKline

Related records

Subsidiaries (4)

• Corixa Corporation Direct subsidiary
• Glaxo Wellcome Direct subsidiary
• SmithKline Beecham Direct subsidiary
• ViiV Healthcare Direct subsidiary

Trials (4,933)

• "Completeness of Response" Following Treatment With Treximet™ for Migraine
• "Pharmacokinetic Study of Fondaparinux in Inpatients With Renal Dysfunction"
• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
• [11C]Carfentanil PET Study of GSK1521498
• [18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer
• [18F]PBR111 and Microglial Activation in Multiple Sclerosis
• 12 Week Patient Study in Neovascular Age-related Macular Degeneration (AMD)
• 12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
• 15-Day Repeated-Dose Study With SB-649868 And Its Interaction With CYP3A4 Isoenzyme In Healthy Male Subjects.
• 24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes
• 24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
• 24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
• 28 Day Repeat Dose in Cystic Fibrosis Patients
• 28-day Repeat Dose and Drug Interaction Study With Orvepitant (GW823296)
• 28-day Repeat Dose Study of GSK573719
• 28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men
• 3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age
• 3 Month PHI PAD PoM Study
• 31P MRS Ischaemic Exercise Optimisation and COPD
• 4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis